CD19 and acute lymphoblastic leukemia: Moreover, upon being transplanted into mice with allogeneic B-ALL developed from the Nalm6-Luc cells, CD19.BBz.PD-L1 CAR T cells were much more efficient in cancer inhibition than the CD19.BBz CAR T cells (Figure 5).